Drug glycosides: potential prodrugs for colon-specific drug delivery.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00379A012PMID 3965714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria.

  1984cited by this paper
• A polymeric drug for treatment of inflammatory bowel disease.

  1983cited by this paper
• Reduction of Polymeric Azo and Nitro Dyes by Intestinal Bacteria

  1981cited by this paper
• A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds.

  1980cited by this paper
• The comparative prophylactic effects of sulphasalazine, prednisolone and azathioprine in experimental colonic ulceration

  1980cited by this paper
• Fecalase: a model for activation of dietary glycosides to mutagens by intestinal flora.

  1980cited by this paper
• Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources.

  1979cited by this paper
• Bacteriological studies of experimental ulcerative colitis.

  1979cited by this paper
• Mutagens in coffee and tea.

  1979cited by this paper
• Protective effect of metronidazole in experimental ulcerative colitis.

  1978cited by this paper
• Thermodynamic analysis of nonelectrolyte permeation across the toad urinary bladder

  1976cited by this paper
• Rationale for design of biologically reversible drug derivatives: prodrugs.

  1975cited by this paper
• A re-evaluation of the importance of partition coefficients in the gastrointestinal absorption of anutrients.

  1974cited by this paper
• Distribution studies of salicylazosulfapyridine and its metabolites.

  1973cited by this paper
• Intestinal bacteria and the hydrolysis of glycosidic bonds.

  1971cited by this paper
• Isolation of 17-alpha-estradiol 17-beta-D-glucopyranoside from rabbit urine, and its synthesis and characterization.

  1969cited by this paper
• Biological membranes: the physical basis of ion and nonelectrolyte selectivity.

  1969cited by this paper
• Drug metabolism by intestinal microorganisms.

  1968cited by this paper
• Mutagenicity of Cycasin Aglycone (Methylazoxymethanol), a Naturally Occurring Carcinogen

  1966cited by this paper

• Overview: Review on colon drug delivery system

  2025cites this paper
• ADVANCING COLON-TARGETED BUDESONIDE DELIVERY: A REVIEW OF THE LATEST DEVELOPMENTS AND FUTURE PERSPECTIVES

  2025cites this paper
• Divergent synthesis of fractionated Cannabis sativa extract led to multiple cannabinoids C-&O-glycosides with anti-proliferative/anti-metastatic properties.

  2023cites this paper
• Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease

  2022cites this paper
• Novel Approaches For Colon Site-Specific Drug Delivery: An Overview Of Recent Advancements

  2022cites this paper
• Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment.

  2022cites this paper
• Colorectal cancer management: strategies in drug delivery

  2022cites this paper
• Development and in vitro study of Metronidazole loaded cross linked sodium alginate and gellan gum microspheres

  2022cites this paper
• Inulin as a delivery vehicle for targeting colon-specific cancer.

  2020cites this paper
• Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives.

  2019cites this paper
• Colonic Drug Delivery Systems as Multiunit Potential: Therapeutic Strategies and Opportunities

  2019cites this paper
• Advanced colon-specific delivery systems for treating local disorders

  2019cites this paper
• The synthesis of vitamin E sugar 1,2-orthoesters

  2019cites this paper
• Intestinal targeting of small molecule MMP and TGR5 ligands for inflammatory bowel disease

  2018cites this paper
• Cannabinoid glycosides: In vitro production of a new class of cannabinoids with improved physicochemical properties

  2017cites this paper
• Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using 18F-FDG PET/CT for Monitoring Treatment Response

  2016cites this paper
• Formulation, gastrointestinal transit studies and absorption of amphotericin B-containing solid lipid nanoparticles in rats

  2016cites this paper
• 5-Aminosalyclic Acid (5-ASA): A Unique Anti-Inflammatory Salicylate

  2016cites this paper
• MEDICINAL PRODRUGS APPROACHES FOR COLON TARGETED RELEASE: A REVIEW

  2016cites this paper
• Non-systemic Intestine-Targeted Drugs.

  2016cites this paper
• Isolation, Purification and Characterization of a Novel Steroidal Saponin Cholestanol Glucoside from Lasiodiplodia theobromae that Induces Apoptosis in A549 Cells.

  2016cites this paper
• Bile acids regulate colonic epithelial barrier function: implications for pathogenesis and therapy of inflammatory bowel disease

  2015cites this paper
• COLON TARGETED DRUG DELIVERY SYSTEM TO TREAT COLORECTAL CANCER: A REVIEW

  2015cites this paper
• Targeted Drug Delivery Systems: Strategies and Challenges

  2015cites this paper
• COLON TARGETED DRUG DELIVERY SYSTEM-AN APPROACH FOR TREATING COLONIC AILMENTS

  2015cites this paper
• FACULTAD DE FARMACIA UNIVERSIDAD COMPLUTENSE

  2015cites this paper
• Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches

  2015cites this paper
• Dérivé de saccharide d'une charge utile toxique et conjugués d'anticorps de celui-ci

  2015cites this paper
• Novel prospective in colon specific drug delivery system.

  2014cites this paper
• Synthesis of phenylazonaphtol-β-D-O-glycosides, evaluation as substrates for beta-glycosidase activity and molecular studies

  2014cites this paper
• Overcoming therapeutic obstacles in inflammatory bowel diseases: a comprehensive review on novel drug delivery strategies.

  2013cites this paper
• Glycyrrhizin Enhances Therapeutic Activity of a Colon-Specific Methylprednisolone Prodrug Against Experimental Colitis

  2013cites this paper
• Drug-glycosidation and drug development.

  2013cites this paper
• Intestinal targeting of drugs: rational design approaches and challenges.

  2013cites this paper
• COLON TARGETED DRUG DELIVERY SYSTEMS-RECENT UPDATES

  2013cites this paper
• Proficient synthesis of biologically active pregnane derivatives and its glycoside – Experimental and theoretical approach

  2013cites this paper
• Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole

  2012cites this paper
• COLON SPECIFIC DELIVERY SYSTEM: THE LOCAL DRUG TARGETING

  2012cites this paper
• Colon Targeting Drug - Synthesis and evaluation of prodrugs ofQuiniodochlor by -Glucosidase enzyme with HPLC methodology

  2012cites this paper
• ANITINERARY TO ACCESS THE COLON

  2012cites this paper
• Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon‐specific glucocorticoid 21‐sulfate sodium at the target site

  2012cites this paper
• Drug Targeting in IBD Treatment – Existing and New Approaches

  2012cites this paper
• Drug and Cell Delivery Systems in the Treatment of Colitis

  2012cites this paper
• Re view Article COLON SPECIFIC DELIVERY SYSTEM : THE LOCAL D RUG TARGETING

  2011cites this paper
• Animal Model Systems Suitable for Controlled Release Modeling

  2011cites this paper
• Reducing Presystemic Drug Metabolism

  2011cites this paper
• Synthesis and characterization of poly{N‐[3‐(dimethylamino) propyl] methacrylamide‐co‐itaconic acid} hydrogels for drug delivery

  2011cites this paper
• Structural effects of N‐aromatic acyl‐amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon‐specific prodrug with controlled conversion rate at the target site

  2011cites this paper
• Rational design and development of colon-specific prodrugs.

  2011cites this paper
• Molecular design, synthesis and bioactivity of glycosyl hydrazine and hydrazone derivatives: notable effects of the sugar moiety.

  2011cites this paper
• Recent trends in microbially and/or enzymatically driven colon-specific drug delivery systems.

  2011cites this paper
• Colon targeted drug delivery systems: a review on primary and novel approaches.

  2010cites this paper
• What should be considered on design of a colon-specific prodrug?

  2010cites this paper
• pH-Sensitive mesoporous zirconium diphosphonates for controllable colon-targeted delivery

  2010cites this paper
• 5-Fluorouracil acetic acid/beta-cyclodextrin conjugates: drug release behavior in enzymatic and rat cecal media.

  2010cites this paper
• Primary and novel approaches for colon targeted drug delivery - A review

  2010cites this paper
• Orally Administered Drug Delivery Systems to the Colon

  2010cites this paper
• Targeted Drug Delivery of Capecitabine Microspheres for Colorectal Cancer

  2009cites this paper
• Dexamethasone 21-Sulfate Improves the Therapeutic Properties of Dexamethasone Against Experimental Rat Colitis by Specifically Delivering the Steroid to the Large Intestine

  2009cites this paper
• Synthesis and evaluation of N-nicotinoyl-2-{2-(2-methyl-5-nitroimidazol-1-yl)ethyloxy}-D,L-glycine as a colon-specific prodrug of metronidazole.

  2009cites this paper
• Sulfate-conjugated methylprednisolone as a colon-targeted methylprednisolone prodrug with improved therapeutic properties against rat colitis

  2009cites this paper
• Sulfate-conjugated methylprednisolone: Evaluation as a colon-specific methylprednisolone prodrug and comparison with sulfate-conjugated prednisolone and dexamethasone

  2009cites this paper
• Designing Prodrugs and Bioprecursors

  2008cites this paper
• Therapeutic opportunities in colon-specific drug-delivery systems.

  2007cites this paper
• Synthesis and in vitro properties of dexamethasone 21-sulfate sodium as a colon-specific prodrug of dexamethasone.

  2006cites this paper
• Colon drug delivery

  2006cites this paper
• Colon drug delivery

  2006cites this paper
• New oral delivery systems for treatment of inflammatory bowel disease.

  2005cites this paper
• Polymer colon drug delivery systems and their application to peptides, proteins, and nucleic acids

  2005cites this paper
• Design and evaluation of cyclodextrin-based drug formulation.

  2004cites this paper
• [Pharmaceutical application of cyclodextrins as multi-functional drug carriers].

  2004cites this paper
• Microbially triggered drug delivery to the colon.

  2003cites this paper
• Pharmaceutical approaches to colon targeted drug delivery systems.

  2003cites this paper
• Synthesis andin vitro properties of prednisolone 21-sulfate sodium as a colon-specific prodrug of prednisolone

  2003cites this paper
• Prednisolone 21‐sulfate sodium: a colon‐specific pro‐drug of prednisolone

  2003cites this paper
• The use of polysaccharides to target drugs to the colon

  2002cites this paper
• Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration.

  2002cites this paper
• Colonic Drug Delivery: Prodrug Approach

  2001cites this paper
• Polysaccharides in colon-specific drug delivery.

  2001cites this paper
• Synthesis and Properties of Dextran–Nalidixic Acid Ester as a Colon-Specific Prodrug of Nalidixic Acid

  2001cites this paper
• Hydrogels Formed by Cross-Linked Polyvinylalcohol as Colon-Specific Drug Delivery Systems

  2001cites this paper
• Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs.

  1999cites this paper
• Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery.

  1999cites this paper
• Local anti-inflammatory activity and systemic side effects of NM-135, a new prodrug glucocorticoid, in an experimental inflammatory rat model.

  1998cites this paper
• Colonic drug targeting.

  1998cites this paper
• Steady‐state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats

  1997cites this paper
• Peptide drug delivery: Colonic and rectal absorption

  1997cites this paper
• [Prodrugs for colon targeting].

  1997cites this paper
• Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation

  1997cites this paper
• Prodrugs für das Dickdarm‐Targeting

  1997cites this paper
• Colonic Drug Delivery

  1997cites this paper
• Physiology of the colorectal barrier

  1997cites this paper
• Colon-specific prodrugs of 5-radioiodo-2'-deoxyuridine.

  1996cites this paper
• Prodrugs and targeted drug delivery

  1996cites this paper
• Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets

  1996cites this paper
• In vitro degradation by colonic bacteria of inulinHP incorporated in Eudragit RS films

  1996cites this paper
• Identification of beta-glucuronidase-resistant diastereomeric glucuronides of 3-hydroxy-3-methyloxindole formed during 3-methylindole metabolism in goats.

  1996cites this paper
• A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women.

  1996cites this paper
• Oral colon-specific drug delivery: a review

  1995cites this paper
• Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.

  1995cites this paper